Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Treatment of sarcoidosis patients by steroid aerosol: a ten-year prospective study from Eastern India.

Identifieur interne : 000568 ( PubMed/Curation ); précédent : 000567; suivant : 000569

Treatment of sarcoidosis patients by steroid aerosol: a ten-year prospective study from Eastern India.

Auteurs : S K Gupta [Inde]

Source :

RBID : pubmed:2727421

Descripteurs français

English descriptors

Abstract

In a consecutive series of 113 cases of biopsy - proven sarcoidosis from Eastern India (1972-1986), steroid aerosols were used in 345 episodes, either alone or with one of the non-steroidal anti-inflammatory drugs (and added chloroquin) or with oral steroids. These, being analysed in detail, revealed satisfactory results only when used with other drugs. Used alone, its role is limited due to high cost, absence of systemic action unless used in high dosage, "hand to lung" delivery problem and difficulty of using in children. It is unsuitable in cases with life - threatening symptoms, neurological or cardiac problems. If used judiciously with suitable companion drugs, it can be used very effectively and can replace oral steroids in many patients.

PubMed: 2727421

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:2727421

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Treatment of sarcoidosis patients by steroid aerosol: a ten-year prospective study from Eastern India.</title>
<author>
<name sortKey="Gupta, S K" sort="Gupta, S K" uniqKey="Gupta S" first="S K" last="Gupta">S K Gupta</name>
<affiliation wicri:level="1">
<nlm:affiliation>Sarcoidosis Unit, Calcutta Medical Research Institute, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Sarcoidosis Unit, Calcutta Medical Research Institute</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1989">1989</date>
<idno type="RBID">pubmed:2727421</idno>
<idno type="pmid">2727421</idno>
<idno type="wicri:Area/PubMed/Corpus">000568</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000568</idno>
<idno type="wicri:Area/PubMed/Curation">000568</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000568</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Treatment of sarcoidosis patients by steroid aerosol: a ten-year prospective study from Eastern India.</title>
<author>
<name sortKey="Gupta, S K" sort="Gupta, S K" uniqKey="Gupta S" first="S K" last="Gupta">S K Gupta</name>
<affiliation wicri:level="1">
<nlm:affiliation>Sarcoidosis Unit, Calcutta Medical Research Institute, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Sarcoidosis Unit, Calcutta Medical Research Institute</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Sarcoidosis</title>
<idno type="ISSN">0393-1447</idno>
<imprint>
<date when="1989" type="published">1989</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Administration, Inhalation</term>
<term>Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)</term>
<term>Beclomethasone (administration & dosage)</term>
<term>Beclomethasone (therapeutic use)</term>
<term>Chloroquine (therapeutic use)</term>
<term>Drug Therapy, Combination</term>
<term>Humans</term>
<term>India</term>
<term>Prospective Studies</term>
<term>Sarcoidosis (drug therapy)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Administration par inhalation</term>
<term>Anti-inflammatoires non stéroïdiens (usage thérapeutique)</term>
<term>Association de médicaments</term>
<term>Béclométasone (administration et posologie)</term>
<term>Béclométasone (usage thérapeutique)</term>
<term>Chloroquine (usage thérapeutique)</term>
<term>Humains</term>
<term>Inde</term>
<term>Sarcoïdose (traitement médicamenteux)</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Beclomethasone</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Anti-Inflammatory Agents, Non-Steroidal</term>
<term>Beclomethasone</term>
<term>Chloroquine</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>India</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Béclométasone</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Sarcoidosis</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Sarcoïdose</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Anti-inflammatoires non stéroïdiens</term>
<term>Béclométasone</term>
<term>Chloroquine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Administration, Inhalation</term>
<term>Drug Therapy, Combination</term>
<term>Humans</term>
<term>Prospective Studies</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Administration par inhalation</term>
<term>Association de médicaments</term>
<term>Humains</term>
<term>Inde</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Inde</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">In a consecutive series of 113 cases of biopsy - proven sarcoidosis from Eastern India (1972-1986), steroid aerosols were used in 345 episodes, either alone or with one of the non-steroidal anti-inflammatory drugs (and added chloroquin) or with oral steroids. These, being analysed in detail, revealed satisfactory results only when used with other drugs. Used alone, its role is limited due to high cost, absence of systemic action unless used in high dosage, "hand to lung" delivery problem and difficulty of using in children. It is unsuitable in cases with life - threatening symptoms, neurological or cardiac problems. If used judiciously with suitable companion drugs, it can be used very effectively and can replace oral steroids in many patients.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">2727421</PMID>
<DateCompleted>
<Year>1989</Year>
<Month>07</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised>
<Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0393-1447</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>6</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1989</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>Sarcoidosis</Title>
<ISOAbbreviation>Sarcoidosis</ISOAbbreviation>
</Journal>
<ArticleTitle>Treatment of sarcoidosis patients by steroid aerosol: a ten-year prospective study from Eastern India.</ArticleTitle>
<Pagination>
<MedlinePgn>51-4</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>In a consecutive series of 113 cases of biopsy - proven sarcoidosis from Eastern India (1972-1986), steroid aerosols were used in 345 episodes, either alone or with one of the non-steroidal anti-inflammatory drugs (and added chloroquin) or with oral steroids. These, being analysed in detail, revealed satisfactory results only when used with other drugs. Used alone, its role is limited due to high cost, absence of systemic action unless used in high dosage, "hand to lung" delivery problem and difficulty of using in children. It is unsuitable in cases with life - threatening symptoms, neurological or cardiac problems. If used judiciously with suitable companion drugs, it can be used very effectively and can replace oral steroids in many patients.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gupta</LastName>
<ForeName>S K</ForeName>
<Initials>SK</Initials>
<AffiliationInfo>
<Affiliation>Sarcoidosis Unit, Calcutta Medical Research Institute, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Italy</Country>
<MedlineTA>Sarcoidosis</MedlineTA>
<NlmUniqueID>8500778</NlmUniqueID>
<ISSNLinking>0393-1447</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>886U3H6UFF</RegistryNumber>
<NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>KGZ1SLC28Z</RegistryNumber>
<NameOfSubstance UI="D001507">Beclomethasone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001507" MajorTopicYN="N">Beclomethasone</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012507" MajorTopicYN="N">Sarcoidosis</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>1989</Year>
<Month>3</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>1989</Year>
<Month>3</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>1989</Year>
<Month>3</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">2727421</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000568 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000568 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:2727421
   |texte=   Treatment of sarcoidosis patients by steroid aerosol: a ten-year prospective study from Eastern India.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:2727421" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a ChloroquineV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021